Paper · 1244564
Prediction of creatinine clearance from serum creatinine.
Cockcroft DW and 1 other. Nephron, 1976. Cited by 13,206 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Prediction of creatinine clearance from serum creatinine. Papers, record 1244564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1244564
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Creatinine | Major topic |
| Kidney | Major topic |
| Adolescent | |
| Adult | |
| Age Factors | |
| Aged | |
| Body Weight | |
| Humans | |
| Male | |
| Mathematics | |
| Methods | |
| Middle Aged |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials19
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00475059 | Performance of Cimetidine-corrected MDRD Equation in Renal Transplant Patients | Background | ClinicalTrials.gov | |
| NCT00551655 | Impact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected Patients | Background | ClinicalTrials.gov | |
| NCT01426165 | Effect of Magnesium Sulfate Infusion Rate on Magnesium Retention in Critically Ill Patients | Background | ClinicalTrials.gov | |
| NCT01445392 | SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma | Background | ClinicalTrials.gov | |
| NCT02103335 | Combination Study of Pomalidomide, Marizomib, and Low-Dose Dexamethasone in Relapsed and Refractory Multiple Myeloma | Background | ClinicalTrials.gov | |
| NCT02104804 | Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin Combined With Metformin in Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control | Results | ClinicalTrials.gov | |
| NCT02308254 | Drug Trial of Lixisenatide on Gastric Emptying and Blood Pressure Drops in Type 2 Diabetics and Healthy People | Background | ClinicalTrials.gov | |
| NCT02324010 | Effects of Sitagliptin on Gastric Emptying, Glycaemia and Blood Pressure in Type 2 Diabetes | Background | ClinicalTrials.gov | |
| NCT02734069 | Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLC | Background | ClinicalTrials.gov | |
| NCT03823365 | Blinatumomab Expanded T-cells (BET) in Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia | Background | ClinicalTrials.gov |
1 to 10 of 19
See all 19 trialsComments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by4,337
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13,206 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,983,577 | Physiological determinants of piperacillin and cefazolin clearance in septic and trauma patients. | Crit Care | 2026 | https://conductscience.org/library/papers/42983577 | PubMed |
| 42,963,461 | Vancomycin Pharmacokinetics and Nephrotoxicity in Kidney Transplant Recipients: A Retrospective Cohort Study. | AAPS J | 2026 | https://conductscience.org/library/papers/42963461 | PubMed |
| 42,941,527 | Analgesic Prescribing in Medically Complex Adult Outpatients Aged ≥40 Years: A Hierarchical Analysis of Comorbidity-Associated Patterns. | J Clin Med | 2026 | https://conductscience.org/library/papers/42941527 | PubMed |
| 42,909,574 | Early Trough Prediction Error of Japanese Population Pharmacokinetic Models for Teicoplanin After Loading in Cancer Patients. | Eur J Drug Metab Pharmacokinet | 2026 | https://conductscience.org/library/papers/42909574 | PubMed |
| 42,908,773 | External validation of EuroSCORE II, additive EuroSCORE, and the STS predicted risk of mortality at 2,600 meters above sea level: a retrospective cohort study from a Latin American cardiac surgery centre. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42908773 | PubMed |
| 42,900,317 | Bladder preservation is still feasible in the rare aggressive small cell carcinoma subtype. | Med Oncol | 2026 | https://conductscience.org/library/papers/42900317 | PubMed |
| 42,894,723 | Application of Machine Learning Models to Predict Tigecycline Exposure in Critically Ill Patients Using Different Limited Sampling Strategies. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42894723 | PubMed |
| 42,875,613 | Estimation of glomerular filtration rate by standard renal CT imaging. | Insights Imaging | 2026 | https://conductscience.org/library/papers/42875613 | PubMed |
| 42,872,928 | Population pharmacokinetics of piperacillin based on multicenter data to support model-informed precision dosing in critically ill women. | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/42872928 | PubMed |
| 42,869,948 | Joint association of growth hormone and cerebral small vessel disease with antihypertensive treatment burden after stroke: an exploratory prospective study. | J Hum Hypertens | 2026 | https://conductscience.org/library/papers/42869948 | PubMed |
1 to 10 of 4,337
See all 4,337 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs3
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| BRENTUXIMAB VEDOTIN | CHEMBL1742994 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1742994 | ChEMBL |
| SAXAGLIPTIN | CHEMBL2103745 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL2103745 | ChEMBL |
| PEMBROLIZUMAB | CHEMBL3137343 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL3137343 | ChEMBL |
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1244564
GET https://conductscience.org/api/papers/v1/1244564/cited_by?page=2